Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters











Language
Publication year range
1.
PLoS One ; 10(9): e0139243, 2015.
Article in English | MEDLINE | ID: mdl-26418693

ABSTRACT

Formylated peptides are chemotactic agents generated by pathogens. The most relevant peptide is fMLF (formyl-Met-Leu-Phe) which participates in several immune functions, such as chemotaxis, phagocytosis, cytokine release and generation of reactive oxygen species. In macrophages fMLF-dependent responses are dependent on both, an increase in intracellular calcium concentration and on a hyperpolarization of the membrane potential. However, the molecular entity underlying this hyperpolarization remains unknown and it is not clear whether changes in membrane potential are linked to the increase in intracellular Ca2+. In this study, differentiated U937 cells, as a macrophage-like cell model, was used to characterize the fMLF response using electrophysiological and Ca2+ imaging techniques. We demonstrate by means of pharmacological and molecular biology tools that fMLF induces a Ca2+-dependent hyperpolarization via activation of the K+ channel KCa3.1 and thus, enhancing fMLF-induced intracellular Ca2+ increase through an amplification of the driving force for Ca2+ entry. Consequently, enhanced Ca2+ influx would in turn lengthen the hyperpolarization, operating as a positive feedback mechanism for fMLF-induced Ca2+ signaling.


Subject(s)
Calcium Signaling/drug effects , Calcium/metabolism , Intermediate-Conductance Calcium-Activated Potassium Channels/metabolism , N-Formylmethionine Leucyl-Phenylalanine/pharmacology , Cell Differentiation/drug effects , Cyclic CMP/analogs & derivatives , Cyclic CMP/pharmacology , Feedback, Physiological/drug effects , Humans , Intermediate-Conductance Calcium-Activated Potassium Channels/genetics , Ion Channel Gating/drug effects , Ion Channel Gating/genetics , Ion Channel Gating/physiology , Membrane Potentials/drug effects , Monocytes/drug effects , Monocytes/metabolism , Monocytes/physiology , Patch-Clamp Techniques , RNA Interference , U937 Cells
2.
Am J Physiol Gastrointest Liver Physiol ; 296(1): G93-100, 2009 Jan.
Article in English | MEDLINE | ID: mdl-18948439

ABSTRACT

Aquaporin-8 (AQP8) water channels, which are expressed in rat hepatocyte bile canalicular membranes, are involved in water transport during bile formation. Nevertheless, there is no conclusive evidence that AQP8 mediates water secretion into the bile canaliculus. In this study, we directly evaluated whether AQP8 gene silencing by RNA interference inhibits canalicular water secretion in the human hepatocyte-derived cell line, HepG2. By RT-PCR and immunoblotting we found that HepG2 cells express AQP8 and by confocal immunofluorescence microscopy that it is localized intracellularly and on the canalicular membrane, as described in rat hepatocytes. We also verified the expression of AQP8 in normal human liver. Forty-eight hours after transfection of HepG2 cells with RNA duplexes targeting two different regions of human AQP8 molecule, the levels of AQP8 protein specifically decreased by 60-70%. We found that AQP8 knockdown cells showed a significant decline in the canalicular volume of approximately 70% (P < 0.01), suggesting an impairment in the basal (nonstimulated) canalicular water movement. We also found that the decreased AQP8 expression inhibited the canalicular water transport in response either to an inward osmotic gradient (-65%, P < 0.05) or to the bile secretory agonist dibutyryl cAMP (-80%, P < 0.05). Our data suggest that AQP8 plays a major role in water transport across canalicular membrane of HepG2 cells and support the notion that defective expression of AQP8 causes bile secretory dysfunction in human hepatocytes.


Subject(s)
Aquaporins/metabolism , Bile Canaliculi/metabolism , Gene Knockdown Techniques , Hepatocytes/metabolism , RNA Interference , RNA, Small Interfering/metabolism , Water/metabolism , Aquaporins/genetics , Bile Canaliculi/drug effects , Cell Line, Tumor , Cyclic CMP/analogs & derivatives , Cyclic CMP/pharmacology , Hepatocytes/drug effects , Humans , Microscopy, Confocal , Osmosis , Reverse Transcriptase Polymerase Chain Reaction , Time Factors , Transfection
3.
Life Sci ; 82(9-10): 529-35, 2008 Feb 27.
Article in English | MEDLINE | ID: mdl-18221757

ABSTRACT

Calcium is an important second messenger in the rat pineal gland, as well as cAMP. They both contribute to melatonin synthesis mediated by the three main enzymes of the melatonin synthesis pathway: tryptophan hydroxylase, arylalkylamine N-acetyltransferase and hydroxyindole-O-methyltransferase. The cytosolic calcium is elevated in pinealocytes following alpha(1)-adrenergic stimulation, through IP(3)-and membrane calcium channels activation. Nifedipine, an L-type calcium channel blocker, reduces melatonin synthesis in rat pineal glands in vitro. With the purpose of investigating the mechanisms involved in melatonin synthesis regulation by the L-type calcium channel, we studied the effects of nifedipine on noradrenergic stimulated cultured rat pineal glands. Tryptophan hydroxylase, arylalkylamine N-acetyltransferase and hydroxyindole-O-methyltransferase activities were quantified by radiometric assays and 5-hydroxytryptophan, serotonin, N-acetylserotonin and melatonin contents were quantified by HPLC with electrochemical detection. The data showed that calcium influx blockaded by nifedipine caused a decrease in tryptophan hydroxylase activity, but did not change either arylalkylamine N-acetyltransferase or hydroxyindole-O-methyltransferase activities. Moreover, there was a reduction of 5-hydroxytryptophan, serotonin, N-acetylserotonin and melatonin intracellular content, as well as a reduction of serotonin and melatonin secretion. Thus, it seems that the calcium influx through L-type high voltage-activated calcium channels is essential for the full activation of tryptophan hydroxylase leading to melatonin synthesis in the pineal gland.


Subject(s)
Calcium Channels, L-Type/physiology , Pineal Gland/metabolism , Tryptophan Hydroxylase/metabolism , 5-Hydroxytryptophan/metabolism , Acetylserotonin O-Methyltransferase/metabolism , Adrenergic alpha-Agonists/pharmacology , Adrenergic beta-Agonists/pharmacology , Animals , Arylalkylamine N-Acetyltransferase/metabolism , Calcium/metabolism , Calcium Channel Blockers/pharmacology , Chromatography, High Pressure Liquid/methods , Cyclic CMP/analogs & derivatives , Cyclic CMP/pharmacology , Dose-Response Relationship, Drug , Electrochemistry , In Vitro Techniques , Isoproterenol/pharmacology , Melatonin/metabolism , Nifedipine/pharmacology , Norepinephrine/pharmacology , Pineal Gland/cytology , Pineal Gland/drug effects , Rats , Rats, Wistar , Serotonin/analogs & derivatives , Serotonin/metabolism
4.
Curr Aging Sci ; 1(1): 51-5, 2008 Mar.
Article in English | MEDLINE | ID: mdl-20021372

ABSTRACT

BACKGROUND: Diabetes is associated with a pro-inflammatory status characterized by an increased production of inflammatory molecules. Reactive oxygen species (ROS) and cAMP elevating agents represent two molecular systems, normally generated during inflammation. These molecules could be responsible for the alteration of signaling pathways. In the present paper we have studied the correlation between ROS generation and inositolpolyphosphates (InsP(1), InsP(2) InsP(3) and InsP(4)) released by granulocytes from Type 1 diabetic patients (DM1) in the presence or in the absence of cyclic AMP-elevating agents. METHODS: The effect of cAMP on ROS production was quantified in a chemoluminescence assay luminol-dependent (RLU/min). InsP(1), InsP(2) InsP(3) and InsP(4) were quantified by inositol-H(3) in a Beta-counter and the results were expressed as count per minute (CPM). RESULTS: The elevation of intracellular level of cAMP inhibited both InsP(3) and ROS production in granulocytes from healthy subjects and activated in the cells from Type 1 diabetic patients. InsP(1), InsP(2) and InsP(4) did not show significant alteration in both studied cells. There was a significant correlation between InsP(3) and ROS in the presence of elevated content of cAMP. This correlation was observed in a 15 minutes reaction for healthy subjects and in 120 minutes for DM1. CONCLUSIONS: The importance of both InsP(3) release and ROS production in an inflammatory process and tissue pathophysiology in Type 1 diabetic patients is still under debate because hyperglycemia accelerates generation of oxidative stress and may play an important role in the development of complications in diabetes. Thus, our results demonstrated alteration in metabolic response in granulocytes from Type 1 diabetic patients and it may be important for the development of therapeutic processes and drugs that interfere with signaling of ROS generation and may contribute to the improvement of the severe complications of diabetes.


Subject(s)
Cyclic AMP/metabolism , Diabetes Mellitus, Type 1/metabolism , Granulocytes/metabolism , Inositol 1,4,5-Trisphosphate/metabolism , Reactive Oxygen Species/metabolism , Adult , Case-Control Studies , Cyclic CMP/analogs & derivatives , Cyclic CMP/pharmacology , Granulocytes/drug effects , Humans , Kinetics , Middle Aged
5.
Braz J Med Biol Res ; 39(11): 1493-9, 2006 Nov.
Article in English | MEDLINE | ID: mdl-17146562

ABSTRACT

In previous studies, we demonstrated biphasic purinergic effects on prolactin (PRL) secretion stimulated by an adenosine A2 agonist. In the present study, we investigated the role of the activation of adenosine A1 receptors by (R)-N6-(2-phenylisopropyl)adenosine (R-PIA) at the pituitary level in in vitro PRL secretion. Hemipituitaries (one per cuvette in five replicates) from adult male rats were incubated. Administration of R-PIA (0.001, 0.01, 0.1, 1, and 10 microM) induced a reduction of PRL secretion into the medium in a U-shaped dose-response curve. The maximal reduction was obtained with 0.1 microM R-PIA (mean +/- SEM, 36.01 +/- 5.53 ng/mg tissue weight (t.w.)) treatment compared to control (264.56 +/- 15.46 ng/mg t.w.). R-PIA inhibition (0.01 microM = 141.97 +/- 15.79 vs control = 244.77 +/- 13.79 ng/mg t.w.) of PRL release was blocked by 1 microM cyclopentyltheophylline, a specific A1 receptor antagonist (1 microM = 212.360 +/- 26.560 ng/mg t.w.), whereas cyclopentyltheophylline alone (0.01, 0.1, 1 microM) had no effect. R-PIA (0.001, 0.01, 0.1, 1 microM) produced inhibition of PRL secretion stimulated by both phospholipase C (0.5 IU/mL; 977.44 +/- 76.17 ng/mg t.w.) and dibutyryl cAMP (1 mM; 415.93 +/- 37.66 ng/mg t.w.) with nadir established at the dose of 0.1 microM (225.55 +/- 71.42 and 201.9 +/- 19.08 ng/mg t.w., respectively). Similarly, R-PIA (0.01 microM) decreased (242.00 +/- 24.00 ng/mg t.w.) the PRL secretion stimulated by cholera toxin (0.5 mg/mL; 1050.00 +/- 70.00 ng/mg t.w.). In contrast, R-PIA had no effect (468.00 +/- 34.00 ng/mg t.w.) on PRL secretion stimulation by pertussis toxin (0.5 mg/mL; 430.00 +/- 26.00 ng/mg t.w.). These results suggest that inhibition of PRL secretion after A1 receptor activation by R-PIA is mediated by a Gi protein-dependent mechanism.


Subject(s)
Adenosine/analogs & derivatives , Pituitary Gland, Anterior/drug effects , Prolactin/metabolism , Receptor, Adenosine A1/metabolism , Signal Transduction , Adenosine/pharmacology , Animals , Cholera Toxin/pharmacology , Cyclic CMP/analogs & derivatives , Cyclic CMP/pharmacology , Dose-Response Relationship, Drug , Male , Pertussis Toxin/pharmacology , Pituitary Gland, Anterior/metabolism , Radioimmunoassay , Rats , Rats, Wistar , Type C Phospholipases/pharmacology
6.
Rev. bras. pesqui. méd. biol ; Braz. j. med. biol. res;39(11): 1493-1499, Nov. 2006. graf
Article in English | LILACS | ID: lil-437828

ABSTRACT

In previous studies, we demonstrated biphasic purinergic effects on prolactin (PRL) secretion stimulated by an adenosine A2 agonist. In the present study, we investigated the role of the activation of adenosine A1 receptors by (R)-N6-(2-phenylisopropyl)adenosine (R-PIA) at the pituitary level in in vitro PRL secretion. Hemipituitaries (one per cuvette in five replicates) from adult male rats were incubated. Administration of R-PIA (0.001, 0.01, 0.1, 1, and 10 æM) induced a reduction of PRL secretion into the medium in a U-shaped dose-response curve. The maximal reduction was obtained with 0.1 æM R-PIA (mean ± SEM, 36.01 ± 5.53 ng/mg tissue weight (t.w.)) treatment compared to control (264.56 ± 15.46 ng/mg t.w.). R-PIA inhibition (0.01 æM = 141.97 ± 15.79 vs control = 244.77 ± 13.79 ng/mg t.w.) of PRL release was blocked by 1 æM cyclopentyltheophylline, a specific A1 receptor antagonist (1 æM = 212.360 ± 26.560 ng/mg t.w.), whereas cyclopentyltheophylline alone (0.01, 0.1, 1 æM) had no effect. R-PIA (0.001, 0.01, 0.1, 1 æM) produced inhibition of PRL secretion stimulated by both phospholipase C (0.5 IU/mL; 977.44 ± 76.17 ng/mg t.w.) and dibutyryl cAMP (1 mM; 415.93 ± 37.66 ng/mg t.w.) with nadir established at the dose of 0.1 æM (225.55 ± 71.42 and 201.9 ± 19.08 ng/mg t.w., respectively). Similarly, R-PIA (0.01 æM) decreased (242.00 ± 24.00 ng/mg t.w.) the PRL secretion stimulated by cholera toxin (0.5 mg/mL; 1050.00 ± 70.00 ng/mg t.w.). In contrast, R-PIA had no effect (468.00 ± 34.00 ng/mg t.w.) on PRL secretion stimulation by pertussis toxin (0.5 mg/mL; 430.00 ± 26.00 ng/mg t.w.). These results suggest that inhibition of PRL secretion after A1 receptor activation by R-PIA is mediated by a Gi protein-dependent mechanism.


Subject(s)
Animals , Male , Rats , Adenosine/analogs & derivatives , Adenosine/pharmacology , Pituitary Gland, Anterior , Prolactin , Receptor, Adenosine A1/metabolism , Signal Transduction , Cholera Toxin/pharmacology , Cyclic CMP/pharmacology , Dose-Response Relationship, Drug , Pertussis Toxin/pharmacology , Type C Phospholipases/pharmacology , Pituitary Gland, Anterior/drug effects , Prolactin/drug effects , Radioimmunoassay , Rats, Wistar
7.
Article in English | MEDLINE | ID: mdl-6206682

ABSTRACT

The role of cyclic nucleotides and Ca2+ on RNA synthesis was investigated in beef thyroid slices. Both cyclic AMP and cyclic GMP caused a significant stimulation of 3H-uridine incorporation into total RNA (around 500%). No additive effect was observed when slices were incubated with cAMP plus cGMP. Another cyclic nucleotide, cyclic 3'5' cytidine monophosphate (cCMP) was also studied. At 0.2 mM cCMP the stimulatory action of cGMP was no longer evident (control 2183 +/- 311 cpm/mg RNA; 0.5 mM cGMP 3849 +/- 316; 0.2 mM cCMP 1885 +/- 238; cGMP + cCMP 1750 +/- 178), extending our previous observation on the blocking effect of cCMP on cAMP stimulation of RNA synthesis. The distribution of uridine nucleotides, precursors of RNA, was studied by paper chromatography in slices labeled with 3H-uridine. Both cAMP and cGMP caused a significant increase in labeled UTP (% UTP in chromatogram: control 2.4 +/- 0.4; 1 mM cAMP 4.9 +/- 1.3 and 1 mM cGMP 5.3 +/- 0.5). The influence of Ca2+ on RNA labeling was studied by incubating the slices under mild Ca2+ depletion (KRB without Ca2+) and severe Ca2+ depletion (KRB without Ca2+ + 2 mM EGTA). Basal RNA labeling was significantly affected only by severe depletion (control 1312 +/- 50; severe Ca2+ depletion 912 +/- 190). Under this latter condition, RNA synthesis failed to respond to TSH, cAMP and cGMP stimulation, and EM showed severe alterations in structure (e.g., nuclear swelling, mitochondrial condensation, etc.).(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Calcium/pharmacology , Norepinephrine/pharmacology , Nucleotides, Cyclic/pharmacology , RNA/biosynthesis , Thyroid Gland/metabolism , Uridine/metabolism , Animals , Chromatography, Paper , Cyclic AMP/pharmacology , Cyclic CMP/pharmacology , Cyclic GMP/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL